Europe approves Mundipharma’s Neulasta biosimilar
The European Commission approved a pegfilgrastim biosimilar from Mundipharma after the network acquired Cinfa Biotech.
The European Commission approved a pegfilgrastim biosimilar from Mundipharma after the network acquired Cinfa Biotech.
The CDMO has broken ground on its first site outside of China – a €325m single-use manufacturing facility in County Louth, Ireland.